Myelosuppression by sunitinib is flt-3 genotype dependent

Br J Cancer. 2010 Aug 24;103(5):757-8. doi: 10.1038/sj.bjc.6605813. Epub 2010 Aug 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Humans
  • Indoles / adverse effects*
  • Leukopenia / chemically induced*
  • Leukopenia / genetics*
  • Polymorphism, Genetic
  • Pyrroles / adverse effects*
  • Sunitinib
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / genetics*
  • fms-Like Tyrosine Kinase 3 / genetics*

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3
  • Sunitinib